Tolazamide
CAS No. 1156-19-0
Tolazamide( NSC 70762 )
Catalog No. M10547 CAS No. 1156-19-0
Tolazamide is an oral blood glucose lowering drug used for people with Type 2 diabetes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 53 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 46 | In Stock |
|
| 10MG | 61 | In Stock |
|
| 25MG | 93 | In Stock |
|
| 50MG | 118 | In Stock |
|
| 100MG | 152 | In Stock |
|
| 200MG | 226 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTolazamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionTolazamide is an oral blood glucose lowering drug used for people with Type 2 diabetes.
-
DescriptionTolazamide is an oral blood glucose lowering drug used for people with Type 2 diabetes.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC 70762
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorPotassium Channel
-
Research AreaEndocrinology
-
Indication——
Chemical Information
-
CAS Number1156-19-0
-
Formula Weight311.4
-
Molecular FormulaC14H21N3O3S
-
Purity>98% (HPLC)
-
SolubilityWater: 65.4 mg/L (at 30 °C)
-
SMILESO=C(NS(=O)(C1=CC=C(C)C=C1)=O)NN2CCCCCC2
-
Chemical Name1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Margatoxin
Potent KV1.3 channel blocker (IC50 = 36 pM). Displays no effect at calcium-activated channels. Reduces VEGF-induced transmembrane calcium influxes and nitric oxide production in human endothelial cells.
-
XE-991
XE-991 is a potent, selective and orally active blocker of voltage-gated potassium channels Kv7 (KCNQ) that blocks KCNQ1, KCNQ2 and KCNQ2+KCNQ3 with Kd of 0.78, 0.7 and 0.6 uM, respectively.
-
QO-40
QO-40 is a KCNQ2/3 potassium channels activator.QO-40 potently augmented KCNQ2/3 channels expressed in Chinese hamster ovary cells and shifted the half-maximal activation voltage (V(1/2)) in the hyperpolarizing direction.?The V(1/2) was negatively shifted in a concentration-dependent manner.?
Cart
sales@molnova.com